Wenbin Qian

机构：Second Affiliated Hospital of Zhejiang University · ORCID：0000-0002-9817-6674

发表论文 302 篇 · 总被引 13702 次 · h-index 38

代表论文

• Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial (2025 · The Lancet · 被引 20)
• CD33 KO -CD33-mesothelin Loop CAR design avoids fratricide and improves efficacy of iNK cells against acute myeloid leukemia (2025 · Journal for ImmunoTherapy of Cancer · 被引 3)
• China Expert consensus on the application of metagenomic next-generation sequencing for the etiological diagnosis of infections in hematological disorders (2024) (2025 · Blood Science · 被引 3)
• HERV‐K TM Subunit Elicits CD8 + T Cell Anergy and Tumor Immune Evasion via Targeting CD3 Coreceptor ε in AML and PDAC (2025 · Advanced Science · 被引 3)
• Safety and efficacy of semi-dose venetoclax plus azacitidine in unfit acute myeloid leukemia patients in China: a real-world single-center study (2025 · Investigational New Drugs · 被引 2)
• STRaM: A genetic framework for improved cell product provenance for research and clinical translations (2025 · Communications Biology · 被引 1)